Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Teva Pharmaceutical Industries Limited (TEVA.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA
Add to watchlist
2,773.00-56.00 (-1.98%)
At close: 05:24PM IST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.

    Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30% royalties on future salesTeva will receive an exclusive license to bring firibastat to its home market, Israel PARIS, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat difficult-to-treat/resistant hypertension, has today announced the signing of an exclusive

  • Insider Monkey

    Berkshire Hathaway Stock Portfolio: 10 Cheapest Stocks

    In this article, we discuss the best cheap stocks to buy in Warren Buffett’s 13F portfolio. You can skip our detailed analysis of the billionaire’s hedge fund, and go directly to read Berkshire Hathaway Stock Portfolio: 5 Cheapest Stocks. Warren Buffett is currently serving as the chairman and CEO of his hedge fund, Berkshire Hathaway. […]

  • Business Wire

    Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement

    TEL AVIV, Israel, November 10, 2021--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today the early tender results in connection with its previously announced tender offers (the "Offers") and that it is increasing the combined aggregate purchase price (exclusive of accrued and unpaid interest) (the "Total Maximum Amount") from $3,500,000,000 to $4,000,000,000 for the following series of notes issued by finance subsidiaries of Teva and guaranteed by Teva:

Advertisement
Advertisement